Greenline Partners’s Eli Lilly LLY Stock Holding History

Greenline Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-23	Closed	-$19K	–	388
2025 Q1	$19K	Buy	+23	New	+$19.1K	﹤0.01%	198

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Greenline Partners's LLY Position: Q2 2025 in Review

Greenline Partners sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 23 shares — an estimated $19K sold.

Greenline Partners first reported a position in LLY in Q1 2025 and held it in 1 quarter. The position peaked at $19K in Q1 2025. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

Greenline Partners reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
Greenline Partners sold 23 Eli Lilly shares in Q2 2025, an estimated $19K.
Greenline Partners first reported a position in Eli Lilly in Q1 2025 and held it in 1 quarter.
Greenline Partners's Eli Lilly position peaked at $19K in Q1 2025.
3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Greenline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.